Dawsey Anna C, Hathaway Kathryn L, Kim Susie, Williams Travis J
Loker Hydrocarbon Research Institute and Department of Chemistry, University of Southern California, Los Angeles, California 90089-1661, United States.
J Chem Educ. 2013 Jul 9;90(7):922-925. doi: 10.1021/ed3006902.
Dotarem and Magnevist, two clinically available magnetic resonance imaging (MRI) contrast agents, were assessed in a high school science classroom with respect to which is the better contrast agent. Magnevist, the more efficacious contrast agent, has negative side effects because its gadolinium center can escape from its ligand. However, Dotarem, though a less efficacious contrast agent, is a safer drug choice. After the experiment, students are confronted with the FDA warning on Magnevist, which enabled a discussion of drug efficacy versus safety. We describe a laboratory experiment in which NMR spin lattice relaxation rate measurements are used to quantify the relaxivities of the active ingredients of Dotarem and Magnevist. The spin lattice relaxation rate gives the average amount of time it takes the excited nucleus to relax back to the original state. Students learn by constructing molar relaxivity curves based on inversion recovery data sets that Magnevist is more relaxive than Dotarem. This experiment is suitable for any analytical chemistry laboratory with access to NMR.
钆喷酸葡胺和马根维显是两种临床上可用的磁共振成像(MRI)造影剂,在一所高中科学课堂上对哪一种是更好的造影剂进行了评估。马根维显是更有效的造影剂,但有负面副作用,因为其钆中心会从配体中逸出。然而,钆喷酸葡胺虽然是效果较差的造影剂,但却是更安全的药物选择。实验结束后,学生们看到了美国食品药品监督管理局(FDA)对马根维显的警告,这引发了关于药物疗效与安全性的讨论。我们描述了一个实验室实验,其中利用核磁共振(NMR)自旋晶格弛豫率测量来量化钆喷酸葡胺和马根维显活性成分的弛豫率。自旋晶格弛豫率给出了激发核弛豫回到原始状态所需的平均时间。学生们通过根据反转恢复数据集构建摩尔弛豫率曲线了解到,马根维显比钆喷酸葡胺的弛豫性更强。这个实验适用于任何能使用核磁共振仪的分析化学实验室。